Director of Oncology 

Dr. Willumsen joined Nordic Bioscience in 2012 and assumed the position of department head in oncology in 2016. His research group focuses on the development of blood-based biomarkers to quantify tumor matrix in serum of cancer patients to understand pharmacodynamics/efficacy/resistance mechanisms of treatments. The group's research activities range from biomarker discovery to preclinical and clinical validation of results. In 2022, Dr. Willumsen was appointed as Director of Oncology.

H-index: 21. i10-index: 40. Citations: 1453 as of March 2023.


Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.